Valeriu Aurelian Chirica
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Valeriu Aurelian Chirica has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alexandrina Lizica Dumitrescu
Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Iaşi, Romania
2 shared publications - Carmen Valerica Rîpă
Grigore T. Popa University of Medicine and Pharmacy Iasi, 16 Universitatii Street, 700115 Iasi, Romania
2 shared publications - Claudia Florida Costea
Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
2 shared publications - Irina Florentina BușIlă
Grigore T. Popa" University of Medicine and Pharmacy, Iasi
2 shared publications - Roxana Gabriela Cobzaru
Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iași, Romania
2 shared publications - Roxana Mihaela Barbu
Grigore T. Popa" University of Medicine and Pharmacy, Iasi
2 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (1) , 269-282
Brain under Parasitic Siege — A Comprehensive Descriptive Review of Neuroparasitic Diseases
Parasitic infections of the central nervous system (CNS) represent a significant yet frequently under-recognised cause of neurological morbidity and mortality worldwide. These infections are caused by a diverse range of protozoa, helminths, and free-living amoebae and may lead to acute or chronic neurological manifestations through mechanisms including direct neural invasion, immune-mediated inflammation, vascular compromise, and blood–brain barrier disruption. Clinically, neuroparasitic diseases present with a broad spectrum of symptoms, ranging from seizures and focal neurological deficits to encephalopathy, cognitive impairment, and coma. This narrative review synthesises current evidence published between 2000 and 2025 regarding the pathophysiology, clinicopathological features, diagnostic approaches, and management strategies of major neuroparasitic diseases, including cerebral malaria, neurocysticercosis, neurotoxoplasmosis, human African trypanosomiasis, and amoebic encephalitis. Emphasis is placed on integrating clinical presentation with histopathological and neuroimaging findings to support diagnostic reasoning and therapeutic decision-making. Advances in diagnostic methodologies, including molecular techniques, magnetic resonance imaging, and computed tomography are discussed, alongside emerging perspectives on the potential role of artificial intelligence (AI) in diagnostic support and epidemiological modelling. By consolidating dispersed evidence into a unified framework, this review aims to serve as an educational and interdisciplinary reference for clinicians and researchers encountering neuroparasitic diseases in neurological practice.
- 19 March 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (1) , 269-282
Open AccessBrain under Parasitic Siege — A Comprehensive Descriptive Review of Neuroparasitic Diseases
Parasitic infections of the central nervous system (CNS) represent a significant yet frequently under-recognised cause of neurological morbidity and mortality worldwide. These infections are caused by a diverse range of protozoa, helminths, and free-living amoebae and may lead to acute or chronic neurological manifestations through mechanisms including direct neural invasion, immune-mediated inflammation, vascular compromise, and blood–brain barrier disruption. Clinically, neuroparasitic diseases present with a broad spectrum of symptoms, ranging from seizures and focal neurological deficits to encephalopathy, cognitive impairment, and coma. This narrative review synthesises current evidence published between 2000 and 2025 regarding the pathophysiology, clinicopathological features, diagnostic approaches, and management strategies of major neuroparasitic diseases, including cerebral malaria, neurocysticercosis, neurotoxoplasmosis, human African trypanosomiasis, and amoebic encephalitis. Emphasis is placed on integrating clinical presentation with histopathological and neuroimaging findings to support diagnostic reasoning and therapeutic decision-making. Advances in diagnostic methodologies, including molecular techniques, magnetic resonance imaging, and computed tomography are discussed, alongside emerging perspectives on the potential role of artificial intelligence (AI) in diagnostic support and epidemiological modelling. By consolidating dispersed evidence into a unified framework, this review aims to serve as an educational and interdisciplinary reference for clinicians and researchers encountering neuroparasitic diseases in neurological practice.
- Open Access
- 5 December 2025
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 16 (4) , 295-308
Neurological Implications of T.gondii and the Role of Artificial Intelligence in Parasitic Psychiatry
Toxoplasma gondii (T.gondii), a protozoan parasite with global prevalence, shows a unique neurotropism that allows it to persist chronically within the central nervous system (CNS). While often clinically silent, chronic toxoplasmosis has been increasingly associated with a range of psychiatric conditions, including schizophrenia, bipolar disorder, suicidal behaviour, and potentially Alzheimer’s disease. The underlying mechanisms are multifactorial,involving direct cyst localization, neuroinflammation, altered neurotransmission, and immunomodulation. In parallel, artificial intelligence (AI) and machine learning (ML) tools are transforming the landscape of biomedical research. In the context of T. gondii, these tools are being employed in neuroimaging analysis, behavioural prediction models, and systems-level simulation of brain-parasite interactions. AI has the potential to enhance early detection of neuroanatomical changes, predict psychiatric outcomes based on infection markers, and uncover latent patterns in large-scale datasets. This descriptive review aims to synthesize the current knowledge on the neurological effects of T. gondii infection while highlighting the emerging integration of AI methodologies in parasitic neuroscience. We discuss pathophysiological mechanisms, psychiatric implications, and how computational tools may bridge gaps in understanding this enigmatic pathogen’s impact on the human brain.
- 5 December 2025
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 16 (4) , 295-308
Open AccessNeurological Implications of T.gondii and the Role of Artificial Intelligence in Parasitic Psychiatry
Toxoplasma gondii (T.gondii), a protozoan parasite with global prevalence, shows a unique neurotropism that allows it to persist chronically within the central nervous system (CNS). While often clinically silent, chronic toxoplasmosis has been increasingly associated with a range of psychiatric conditions, including schizophrenia, bipolar disorder, suicidal behaviour, and potentially Alzheimer’s disease. The underlying mechanisms are multifactorial,involving direct cyst localization, neuroinflammation, altered neurotransmission, and immunomodulation. In parallel, artificial intelligence (AI) and machine learning (ML) tools are transforming the landscape of biomedical research. In the context of T. gondii, these tools are being employed in neuroimaging analysis, behavioural prediction models, and systems-level simulation of brain-parasite interactions. AI has the potential to enhance early detection of neuroanatomical changes, predict psychiatric outcomes based on infection markers, and uncover latent patterns in large-scale datasets. This descriptive review aims to synthesize the current knowledge on the neurological effects of T. gondii infection while highlighting the emerging integration of AI methodologies in parasitic neuroscience. We discuss pathophysiological mechanisms, psychiatric implications, and how computational tools may bridge gaps in understanding this enigmatic pathogen’s impact on the human brain.